International Congress of DAO Deficiency'24

Theme: DAO deficiency: aetiology, its different clinical manifestations, its dietary treatment, the regulatory framework, and any research project or innovation on the enzyme diamine oxidase (DAO) and its deficiency activity.

We invite scientists, academics, physicians, nutritionists, pharmacists, as well as professionals from the pharmaceutical and food industries to participate as international experts on DAO deficiency by indicating the topic and content of their papers, whose abstract should be SUBMITTED before 30th NOVEMBER 2023. The proposed content will be reviewed by the Scientific Committee of the III International Congress on DAO Deficiency 2024.

Accepted abstracts will be broadcast live and simultaneously translated into several languages during the congress.

What is the current relevance of DAO deficiency?

For more than 20 years, DAO deficiency has been of great interest to the scientific, medical, pharmaceutical and nutritional communities, as well as the pharmaceutical and food industries, as evidenced by the increasing number of publications each year on this widespread metabolic disorder. It is estimated to affect 15% of the world’s population. Diseases caused by DAO deficiency include neurological conditions such as migraine, gastrointestinal conditions such as irritable bowel disease, dermatological conditions such as dermatitis, dry skin and atopy, psychiatric conditions such as fibromyalgia and chronic fatigue, and psychological conditions such as attention deficit hyperactivity disorder (ADHD).

Numerous clinical studies have demonstrated the beneficial effects of using the enzyme diamine oxidase (DAO) in the dietary management of conditions associated with DAO deficiency. This has led the European Commission to classify the DAO enzyme as a novel food.

This fruitful field of research, regulation and application of the enzyme diamine oxidase deficiency justifies the need to extend the knowledge of this metabolic disorder in the scientific, medical, pharmaceutical and nutritional communities, as well as its applications in the pharmaceutical and food industries, in order to improve the care of patients suffering from DAO deficiency. These are the objectives of the International Congress on DAO Deficiency, which DR Healthcare promotes every year.

Criteria for participation

The topics of interest of the papers should be related to basic and applied clinical research, as well as any other research and innovation content related to DAO deficiency.

If you are interested in participating as an International Expert Speaker on DAO Deficiency for the International Congress of DAO Deficiency 2022, please contact us at congress@dr-healthcare.com with your Curriculum Vitae and the topic you would like to address. The abstract of your presentation should be SUBMITTED by 30 November 2023. They will be reviewed and approved by the Scientific Committee of the II International Congress on DAO Deficiency 2022. We invite you to submit your original research articles and reviews for presentation at the International Congress.

Please do not hesitate to contact us for further information, to determine the suitability of your papers, or to assist you with any other related questions.